The relationship between infections and stroke has not been fully characterized, probably
delaying the development of specific treatments. This narrative review addresses …

Objectives This review aims to identify biological markers of the risk of recurrence of
thrombotic and/or obstetric events in patients with antiphospholipid syndrome (APS) …

In 2006, at a meeting in Sydney, Australia, consensus was reached by an international
group of specialists to establish a number of serological criteria that identify patients with a …

Skin involvement in other autoimmune diseases - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Help Search My account Sign in View PDF Download …

Abstract aPLs are a major determinant of the increased cardiovascular risk in patients with
SLE. They adversely affect clinical manifestations, damage accrual and prognosis. Apart …

Externalized phosphatidylserine (PS) is a phospholipid and a selective marker of the tumor
microenvironment (TME). It is exposed on the outer leaflet of the plasma membrane of tumor …

Antiphospholipid syndrome (APS) was first identified as a distinct syndrome in the early
1980s in patients suffering from lupus with antiphospholipid antibodies (aPL), repeated …

Antiphospholipid syndrome (APS), also known as Hughes syndrome, is an acquired
autoimmune and procoagulant condition that predisposes individuals to recurrent thrombotic …

Background Patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP)
have anti–ADAMTS-13 immunoglobulin G (IgG) autoantibodies that enhance ADAMTS-13 …

Our study aimed to evaluate the presence, clinical associations, and potential mechanistic
roles of non-criteria antiphospholipid antibodies (aPL) and circulating calprotectin, a highly …